Cargando…

Intranasal administration of oxytocin: Behavioral and clinical effects, a review

The intranasal (IN-) administration of substances is attracting attention from scientists as well as pharmaceutical companies. The effects are surprisingly fast and specific. The present review explores our current knowledge about the routes of access to the cranial cavity. ‘Direct-access-pathways’...

Descripción completa

Detalles Bibliográficos
Autores principales: Veening, Jan G., Olivier, Berend
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112651/
https://www.ncbi.nlm.nih.gov/pubmed/23648680
http://dx.doi.org/10.1016/j.neubiorev.2013.04.012
_version_ 1783513514563862528
author Veening, Jan G.
Olivier, Berend
author_facet Veening, Jan G.
Olivier, Berend
author_sort Veening, Jan G.
collection PubMed
description The intranasal (IN-) administration of substances is attracting attention from scientists as well as pharmaceutical companies. The effects are surprisingly fast and specific. The present review explores our current knowledge about the routes of access to the cranial cavity. ‘Direct-access-pathways’ from the nasal cavity have been described but many additional experiments are needed to answer a variety of open questions regarding anatomy and physiology. Among the IN-applied substances oxytocin (OT) has an extensive history. Originally applied in women for its physiological effects related to lactation and parturition, over the last decade most studies focused on their behavioral ‘prosocial’ effects: from social relations and ‘trust’ to treatment of ‘autism’. Only very recently in a microdialysis study in rats and mice, the ‘direct-nose-brain-pathways’ of IN-OT have been investigated directly, implying that we are strongly dependent on results obtained from other IN-applied substances. Especially the possibility that IN-OT activates the ‘intrinsic’ OT-system in the hypothalamus as well needs further clarification. We conclude that IN-OT administration may be a promising approach to influence human communication but that the existing lack of information about the neural and physiological mechanisms involved is a serious problem for the proper understanding and interpretation of the observed effects.
format Online
Article
Text
id pubmed-7112651
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71126512020-04-02 Intranasal administration of oxytocin: Behavioral and clinical effects, a review Veening, Jan G. Olivier, Berend Neurosci Biobehav Rev Article The intranasal (IN-) administration of substances is attracting attention from scientists as well as pharmaceutical companies. The effects are surprisingly fast and specific. The present review explores our current knowledge about the routes of access to the cranial cavity. ‘Direct-access-pathways’ from the nasal cavity have been described but many additional experiments are needed to answer a variety of open questions regarding anatomy and physiology. Among the IN-applied substances oxytocin (OT) has an extensive history. Originally applied in women for its physiological effects related to lactation and parturition, over the last decade most studies focused on their behavioral ‘prosocial’ effects: from social relations and ‘trust’ to treatment of ‘autism’. Only very recently in a microdialysis study in rats and mice, the ‘direct-nose-brain-pathways’ of IN-OT have been investigated directly, implying that we are strongly dependent on results obtained from other IN-applied substances. Especially the possibility that IN-OT activates the ‘intrinsic’ OT-system in the hypothalamus as well needs further clarification. We conclude that IN-OT administration may be a promising approach to influence human communication but that the existing lack of information about the neural and physiological mechanisms involved is a serious problem for the proper understanding and interpretation of the observed effects. Elsevier Ltd. 2013-09 2013-05-04 /pmc/articles/PMC7112651/ /pubmed/23648680 http://dx.doi.org/10.1016/j.neubiorev.2013.04.012 Text en Copyright © 2013 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Veening, Jan G.
Olivier, Berend
Intranasal administration of oxytocin: Behavioral and clinical effects, a review
title Intranasal administration of oxytocin: Behavioral and clinical effects, a review
title_full Intranasal administration of oxytocin: Behavioral and clinical effects, a review
title_fullStr Intranasal administration of oxytocin: Behavioral and clinical effects, a review
title_full_unstemmed Intranasal administration of oxytocin: Behavioral and clinical effects, a review
title_short Intranasal administration of oxytocin: Behavioral and clinical effects, a review
title_sort intranasal administration of oxytocin: behavioral and clinical effects, a review
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112651/
https://www.ncbi.nlm.nih.gov/pubmed/23648680
http://dx.doi.org/10.1016/j.neubiorev.2013.04.012
work_keys_str_mv AT veeningjang intranasaladministrationofoxytocinbehavioralandclinicaleffectsareview
AT olivierberend intranasaladministrationofoxytocinbehavioralandclinicaleffectsareview